Veidlapa Nr. M-3 (8)
Study Course Description
Clinical Pharmacy
Course Code
FFK_018
Branch of Science
Basic medicine; Clinical Pharmacy
ECTS
6.00
Target Audience
Clinical Pharmacy
LQF
Level 7
Study Type And Form
Full-Time
Study Course Implementer
Course Supervisor
Inga Urtāne
Structure Unit Manager
Inga Urtāne
Structural Unit
Department of Pharmacology and Pharmacotherapy
Contacts
Riga, 21 Consula Street, farmkk@rsu.lv, +371 67061544
About Study Course
Objective
Promote knowledge acquisition and awareness raising on clinical pharmacy and the role of a clinical pharmacist in healthcare.
Preliminary Knowledge
Pharmacology, pharmacotherapy, practical pharmacy and pharmaceutical legislation, social pharmacy and pharmaceuticals, English.
Learning Outcomes
Knowledge
1.Upon successful completion of the course, students will have acquired knowledge that will allow to: 1. recognize the scope and tasks of the clinical pharmacist; 2. define and outline the principles for evidence-based drug selection; 3. understand the role of the clinical pharmacist in promoting patient safety; 4. formulate and describe the role and tasks of hospital pharmacy in the healthcare system.
Skills
1.On study course completion students will be able to: 1. identify the areas of activity of the clinical pharmacist; 2. evaluate and explain the role of the clinical pharmacist in the development of a patient safety system; 3. participate in the planning, organization and monitoring of the rational use of funds for the purchase of medicines; 4. participate in the development, maintenance and use of a rational drug information system; 5. participate in the design, implementation and improvement of a system for the detection, analysis and elimination of medication therapy errors.
Competences
1.1. As a result of successful completion of the course students will be able to apply the acquired knowledge in clinical pharmacist's work. 2. Provide advice to health professionals based on guidelines, accepted standards, evidence-based medical knowledge. 3. Will be able to participate in the development of health policy oriented towards rational pharmacotherapy, in the definition of directions and goals of development, in the forecasting and planning of its individual stages. 4. Will be able to fill in the study course questionnaire with proposals for updating the course.
Assessment
Individual work
|
Title
|
% from total grade
|
Grade
|
|---|---|---|
|
1.
Individual work |
-
|
-
|
|
Preparation of presentations according to the topics of the course, work with medical databases, calculation of tasks according to the topics of the lectures. It is recommended to fill in the study course survey, evaluating the existing course content and creating proposals for updating the course.
|
||
Examination
|
Title
|
% from total grade
|
Grade
|
|---|---|---|
|
1.
Examination |
-
|
10 points
|
|
The final assessment of the study course consists of the assessment of presentations (50%) and the examination mark (50%). |
||
Study Course Theme Plan
FULL-TIME
Part 1
-
Lecture
|
Modality
|
Location
|
Contact hours
|
|---|---|---|
|
On site
|
Study room
|
3
|
Topics
|
Information search skills in clinical pharmacist practice. The role of a clinical pharmacist in the hospital’s medicines committee. Drug information centre. Artificial intelligence in clinical decision making.
|
-
Lecture
|
Modality
|
Location
|
Contact hours
|
|---|---|---|
|
Off site
|
Online
|
3
|
Topics
|
Drug interactions and contraindications. Experience in using databases.
|
-
Class/Seminar
|
Modality
|
Location
|
Contact hours
|
|---|---|---|
|
On site
|
Study room
|
3
|
Topics
|
Side effects and withdrawal syndromes.
|
-
Class/Seminar
|
Modality
|
Location
|
Contact hours
|
|---|---|---|
|
On site
|
Study room
|
3
|
Topics
|
The role of a clinical pharmacist in the practice of intensive care units.
|
-
Class/Seminar
|
Modality
|
Location
|
Contact hours
|
|---|---|---|
|
On site
|
Study room
|
3
|
Topics
|
Specificities of the use of the medicinal product for specific groups of patients.
|
-
Lecture
|
Modality
|
Location
|
Contact hours
|
|---|---|---|
|
On site
|
Study room
|
3
|
Topics
|
Options for monitoring the effectiveness and safety of medicinal products. Therapeutic drug monitoring.
|
-
Lecture
|
Modality
|
Location
|
Contact hours
|
|---|---|---|
|
Off site
|
Online
|
3
|
Topics
|
Pharmacotherapeutic problems, case study of drug prescriptions.
|
-
Class/Seminar
|
Modality
|
Location
|
Contact hours
|
|---|---|---|
|
On site
|
Study room
|
3
|
Topics
|
Analysis of drug prescription cases.
|
Total ECTS (Creditpoints):
3.00
Contact hours:
24 Academic Hours
Final Examination:
Test (Semester)
Part 2
-
Lecture
|
Modality
|
Location
|
Contact hours
|
|---|---|---|
|
On site
|
Auditorium
|
3
|
Topics
|
The safety aspect of medicines in healthcare.
|
-
Class/Seminar
|
Modality
|
Location
|
Contact hours
|
|---|---|---|
|
On site
|
Study room
|
3
|
Topics
|
The safety aspect of medicines in healthcare.
|
-
Lecture
|
Modality
|
Location
|
Contact hours
|
|---|---|---|
|
On site
|
Auditorium
|
3
|
Topics
|
Interpretation and analysis of laboratory data within the framework of the use of medicinal products.
|
-
Class/Seminar
|
Modality
|
Location
|
Contact hours
|
|---|---|---|
|
On site
|
Study room
|
3
|
Topics
|
Interpretation and analysis of laboratory data within the framework of the use of medicinal products.
|
-
Lecture
|
Modality
|
Location
|
Contact hours
|
|---|---|---|
|
On site
|
Auditorium
|
3
|
Topics
|
Active substances and excipients — effects zones in the operation of medicines.
|
-
Lecture
|
Modality
|
Location
|
Contact hours
|
|---|---|---|
|
On site
|
Auditorium
|
3
|
Topics
|
Adverse drug reactions – causes, risks, consequences.
|
-
Class/Seminar
|
Modality
|
Location
|
Contact hours
|
|---|---|---|
|
On site
|
Study room
|
3
|
Topics
|
Clinical case presentations.
|
-
Class/Seminar
|
Modality
|
Location
|
Contact hours
|
|---|---|---|
|
On site
|
Study room
|
3
|
Topics
|
Clinical case presentations.
|
Total ECTS (Creditpoints):
3.00
Contact hours:
24 Academic Hours
Final Examination:
Exam (Written)
Bibliography
Required Reading
1.
Clinical Pharmacy and Therapeutics / edited by Cate Whittlesea and Karen Hodson. 6th edition. [Oxford]: Elsevier, 2019. xiv, 1094 lpp.
2.
Haughey, Sharon. Pharmacy OSCES and competency-based assessments / Queen's University, Belfast, Northern Ireland, UK, Roisin O'Hare, BSc, MSc, DPharm, MPSNI(IP), FFRPS, Lead, 2018.
3.
Oxford handbook of clinical pharmacy / edited by Philip Wiffen, Marc Mitchell, Melanie Snelling, Nicola Stoner. 3rd edition. Oxford; New York: Oxford University Press, 2017. xvi, 728 lpp. Oxford medical publications. Oxford handbooks. (brošēts).
Additional Reading
1.
Crombie I.K., Davies H.T. What is meta-analysis? Bandolier, 2009 April [online].
2.
Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ, 2003; 327: 557–560.
3.
Ebell M., Siwek J., Weiss B.D., et al. Strength of Recommendation Taxonomy (SORT): A Patient-Centered Approach to Grading Evidence in the Medical Literature. Am Fam Physician, 2004; 69:548-556.
4.
Guyatt G., Cairns J., Churchill D, et al. Evidence-Based Medicine Working Group. Evidence-based medicine. A new approach to teaching the practice of medicine. JAMA, 1992; 268:2420-2425
5.
Hemingway P. What is a systematic review? Bandolier, 2009 April [online].
6.
Ioannidis J.P., N.A. Patsopoulos, E.Evangelou. Uncertainty in heterogeneity estimates in meta-analyses. BMJ, 2007; 335: 914–916.
7.
Pediatric Medication Errors: Using the National Patient Safety Goals to Protect Patients. The Joint Commission Perspectives on Patient Safety, 2008 June;8(6)
8.
Seven steps to patient safety: A guide for NHS staff. National Patient Safety Agency, 2004.
Other Information Sources
1.
Cochrane library
2.
Pubmed
3.
DynaMed
4.
ClinicalKey First Consult
5.
Micromedex